Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.

ABSTRACT:

Background

Advances in diagnostic and therapeutic strategies in oncology have significantly increased the chance of survival of cancer patients, even those with metastatic disease. However, cancer-related cognitive impairment (CRCI) is frequently reported in patients treated for non-central nervous system cancers, particularly during and after chemotherapy.

Design

This review provides an update of the state of the art based on PubMed searches between 2012 and March 2019 on 'cognition', 'cancer', 'antineoplastic agents' or 'chemotherapy'. It includes the most recent clinical, imaging and pre-clinical data and reports management strategies of CRCI.

Results

Evidence obtained primarily from studies on breast cancer patients highlight memory, processing speed, attention an

SUBMITTER: Lange M 

PROVIDER: S-EPMC8109411 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature